Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. GNTA.NASDAQ

Genenta Science SpA ADR (GNTA NASDAQ) stock market data APIs

$4 -0.19(-4.5%) as of July 26, 2024
Price chart is built with Anychart

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Genenta Science SpA ADR Financial Data Overview

4.19
4
-
4.52
4
2.2-6.09
78 335 K
18 217 K
0
-0.1625
0.759
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GNTA',
Type: 'Common Stock',
Name: 'Genenta Science SpA ADR',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG013GNLJL6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1838716',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-12-15',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Genenta Science SpA ADR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -11 690 489
  • Earnings Per Share -0.69
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Genenta Science SpA ADR Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Genenta Science SpA ADR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Genenta Science SpA ADR latest news via APIs

Genenta to Present at Upcoming Scientific and Investor Conferences

MILAN, Italy and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA) a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of ...
  • CALENDAR OF EVENTS
  • GENENTA SCIENCE SPA
  • HEALTH
  • NASDAQ:GNTA

Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments

Company Selects Refractory Advanced Genitourinary Malignancies including Renal Cell Cancer as Second Indication MILAN, Italy and NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:...
  • BIOTECH
  • CANCER
  • CELL THERAPY
  • GENE THERAPY
  • GENENTA SCIENCE SPA
  • HEALTH
  • NASDAQ:GNTA
  • PHARMA
  • TEMFERON
Do you have any questions?
support@eodhistoricaldata.com